{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:09:45Z","timestamp":1793045385597,"version":"4.5.0"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Health and Medical Research Council (NHMRC) fellowship","award":["1106716"],"award-info":[{"award-number":["1106716"]}],"id":[{"id":"https:\/\/ror.org\/011kf5r70","id-type":"ROR","asserted-by":"crossref"}]},{"name":"NHMRC Early Career Fellowship","award":["1126256"],"award-info":[{"award-number":["1126256"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Pain is a common symptom in people with autosomal dominant polycystic kidney disease (ADPKD), but it is assessed and reported inconsistently in research, and the validity of the measures remain uncertain. The aim of this study was to identify the characteristics, content, and psychometric properties of measures for pain used in ADPKD. We conducted a systematic review including all trials and observational studies that reported pain in people with ADPKD. Items from all measures were categorized into content and measurement dimensions of pain. We assessed the general characteristics and psychometric properties of all measures. 118 studies, we identified 26 measures: 12 (46%) measures were developed for a non-ADPKD population, 1 (4%) for chronic kidney disease, 2 (8%) for polycystic liver disease and 11 (42%) specifically for ADPKD. Ten anatomical sites were included, with the lower back the most common (10 measures [39%]), four measurement dimensions (intensity (23 [88%]), frequency (3 [12%]), temporality (2 [8%]), and sensory (21 [81%]), two pain types, nociceptive including visceral (15 [58%]) and somatic (5 [20%]), and neuropathic (2 [8%]), and twelve impact dimensions, where the most frequent was work (5 [31%]). The validation data for the measures were variable and only the ADPKD Impact Scale reported all psychometric domains. The measures for pain in ADPKD varied in terms of content and length, and most had not been validated in ADPKD. A standardized psychometrically robust measure that captures patient-important dimensions of pain is needed to evaluate and manage this debilitating complication of ADPKD.<\/jats:p>","DOI":"10.1371\/journal.pone.0252479","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T15:31:43Z","timestamp":1622129503000},"page":"e0252479","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Patient-reported outcome measures for pain in autosomal dominant polycystic kidney disease: A systematic review"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2825-2993","authenticated-orcid":true,"given":"Patrizia","family":"Natale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyssa","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Sautenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald D.","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Burnette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5038-7264","authenticated-orcid":true,"given":"Niek","family":"Casteleijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Eastty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Gansevoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Horie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Knebelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem A.","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Sandford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Baumgart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni F. M.","family":"Strippoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopala K.","family":"Rangan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeoungjee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,5,27]]},"reference":[{"issue":"5","key":"pone.0252479.ref001","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1046\/j.1523-1755.2001.00985.x","article-title":"Pain management in polycystic kidney disease","volume":"60","author":"ZH Bajwa","year":"2001","journal-title":"Kidney Int"},{"issue":"3","key":"pone.0252479.ref002","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1053\/j.ajkd.2018.09.016","article-title":"Determinants of Urine Volume in ADPKD Patients Using the Vasopressin V2 Receptor Antagonist Tolvaptan","volume":"73","author":"BJ Kramers","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"pone.0252479.ref003","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/ndt\/gfv010","article-title":"A painful inheritance\u2014patient perspectives on living with polycystic kidney disease: thematic synthesis of qualitative research","volume":"30","author":"A Tong","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"pone.0252479.ref004","doi-asserted-by":"crossref","first-page":"iv142","DOI":"10.1093\/ndt\/gfu073","article-title":"A stepwise approach for effective management of chronic pain in autosomal-dominant polycystic kidney disease","volume":"29","author":"NF Casteleijn","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"pone.0252479.ref005","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2215\/CJN.02410508","article-title":"Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis","volume":"4","author":"D Rizk","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"pone.0252479.ref006","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1053\/j.ajkd.2013.08.017","article-title":"Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1\u20134: A cross-sectional study","volume":"63","author":"DC Miskulin","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"25","key":"pone.0252479.ref007","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"VE Torres","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"pone.0252479.ref008","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1681\/ASN.2009121291","article-title":"Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease","volume":"21","author":"MC Hogan","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"pone.0252479.ref009","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1053\/j.ackd.2010.01.005","article-title":"Evaluation and Management of Pain in Autosomal Dominant Polycystic Kidney Disease","volume":"17","author":"MC Hogan","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"pone.0252479.ref010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2015.59","article-title":"Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference","volume":"88","author":"AB Chapman","year":"2015","journal-title":"Kidney Int"},{"key":"pone.0252479.ref011","unstructured":"Standardized Outcomes in Nephrology-PKD (SONG-PKD) initiative. https:\/\/songinitiativeorg\/projects\/song-pkd\/ [last access March 2021]."},{"key":"pone.0252479.ref012","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/nep.13566","article-title":"Identifying patient-important outcomes in polycystic kidney disease: An international nominal group technique study","author":"Y Cho","year":"2019","journal-title":"Nephrology"},{"key":"pone.0252479.ref013","article-title":"Core Outcome Domains for Trials in Autosomal Dominant Polycystic Kidney Disease: An International Delphi Survey","author":"Y Cho","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"pone.0252479.ref014","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/nep.12658","article-title":"KHA-CARI guideline recommendations for the diagnosis and management of autosomal dominant polycystic kidney disease","volume":"21","author":"GK Rangan","year":"2016","journal-title":"Nephrology"},{"key":"pone.0252479.ref015","article-title":"Range and variability of outcomes reported in randomized trials conducted in polycystic kidney disease: a systematic review","author":"B Sautenet","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"pone.0252479.ref016","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s13063-016-1555-2","article-title":"How to select outcome measurement instruments for outcomes included in a \u201cCore Outcome Set\u201d \u2010 a practical guideline","volume":"17","author":"CA Prinsen","year":"2016","journal-title":"Trials"},{"issue":"1","key":"pone.0252479.ref017","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1148\/radiol.2015141637","article-title":"Transcatheter Arterial Embolization with Ethanol Injection in Symptomatic Patients with Enlarged Polycystic Kidneys","volume":"277","author":"Y Sakuhara","year":"2015","journal-title":"Radiology"},{"key":"pone.0252479.ref018","unstructured":"Short Form\u201412 Health Survey. Available at https:\/\/wwwhoagorthopedicinstitutecom\/documents\/SF12formpdf [last access July 2020]."},{"key":"pone.0252479.ref019","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"M Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"pone.0252479.ref020","unstructured":"Euro Quality of Life\u20145 Dimensions Health Questionnaire. Available at https:\/\/euroqolorg\/eq-5d-instruments\/sample-demo\/ [last access July 2020]."},{"key":"pone.0252479.ref021","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1471-2369-14-179","article-title":"Quality of life of patients with ADPKD-Toranomon PKD QOL study: cross-sectional study","volume":"14","author":"T Suwabe","year":"2013","journal-title":"BMC Nephrol"},{"key":"pone.0252479.ref022","unstructured":"Short Form\u201436 Health Survey. Available at https:\/\/wwwrandorg\/health-care\/surveys_tools\/mos\/36-item-short-form\/survey-instrumenthtml [last access July 2020]."},{"key":"pone.0252479.ref023","unstructured":"European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30). Available at https:\/\/wwweortcorg\/app\/uploads\/sites\/2\/2018\/08\/Specimen-QLQ-C30-Englishpdf [last access July 2020]."},{"issue":"2","key":"pone.0252479.ref024","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1053\/j.ajkd.2017.08.020","article-title":"Development of the Autosomal Dominant Polycystic Kidney Disease Impact Scale: A New Health-Related Quality-of-Life Instrument","volume":"71","author":"D Oberdhan","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"pone.0252479.ref025","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/ndt\/gfx186","article-title":"Effect of renal transcatheter arterial embolization on quality of life in patients with autosomal dominant polycystic kidney disease","volume":"32","author":"T Suwabe","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"pone.0252479.ref026","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.xkme.2019.07.015","article-title":"Foam Sclerotherapy for Cyst Volume Reduction in Autosomal Dominant Polycystic Kidney Disease: A Prospective Cohort Study","volume":"1","author":"IA Iliuta","year":"2019","journal-title":"Kidney Medicine"},{"issue":"1","key":"pone.0252479.ref027","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2013.03.004","article-title":"Everolimus does not further reduce polycystic liver volume when added to long acting octreotide: Results from a randomized controlled trial","volume":"59","author":"M Chrispijn","year":"2013","journal-title":"J Hepatol"},{"issue":"12","key":"pone.0252479.ref028","doi-asserted-by":"crossref","first-page":"e0144526","DOI":"10.1371\/journal.pone.0144526","article-title":"Clinical Correlates of Mass Effect in Autosomal Dominant Polycystic Kidney Disease","volume":"10","author":"H Kim","year":"2015","journal-title":"PLoS ONE"},{"key":"pone.0252479.ref029","unstructured":"Kidney Disease and Quality of Life (KDQOL-SF). Available at https:\/\/wwwrandorg\/content\/dam\/rand\/www\/external\/health\/surveys_tools\/kdqol\/kdqol13pdf [last access July 2020]."},{"issue":"3","key":"pone.0252479.ref030","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/j.ajkd.2005.05.029","article-title":"Earlier diagnosis of autosomal dominant polycystic kidney disease: importance of family history and implications for cardiovascular and renal complications","volume":"46","author":"M Taylor","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"pone.0252479.ref031","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/hep.28545","article-title":"Development and Validation of a Disease-Specific Questionnaire to Assess Patient-Reported Symptoms in Polycystic Liver Disease","volume":"64","author":"MK Neijenhuis","year":"2016","journal-title":"Hepatology"},{"key":"pone.0252479.ref032","unstructured":"Brief Pain Inventory (Short Form). Available at http:\/\/wwwnpcrcorg\/files\/news\/briefpain_shortpdf [last access July 2020]."},{"key":"pone.0252479.ref033","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0304-3959(87)90027-3","article-title":"The McGill Pain Questionnaire constructed for the Dutch language (MPQ-DV). Preliminary data concerning reliability and validity","volume":"30","author":"AH Vanderiet K","year":"1987","journal-title":"Pain"},{"issue":"4","key":"pone.0252479.ref034","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jpain.2015.01.012","article-title":"Validation of the Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2) in Acute Low Back Pain","volume":"16","author":"RH Dworkin","year":"2015","journal-title":"J Pain"},{"issue":"2","key":"pone.0252479.ref035","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2019.04.018","article-title":"Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease","volume":"157","author":"RMM van Aerts","year":"2019","journal-title":"Gastroenterology"},{"issue":"3","key":"pone.0252479.ref036","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jhep.2016.05.009","article-title":"Ursodeoxycholic acid in advanced polycystic liver disease: A phase 2 multicenter randomized controlled trial","volume":"65","author":"HM D\u2019Agnolo","year":"2016","journal-title":"J Hepatol"},{"issue":"3","key":"pone.0252479.ref037","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000479436","article-title":"The Association of Combined Total Kidney and Liver Volume with Pain and Gastrointestinal Symptoms in Patients with Later Stage Autosomal Dominant Polycystic Kidney Disease","volume":"46","author":"HMA D\u2019Agnolo","year":"2017","journal-title":"Am J Nephrol"},{"issue":"5","key":"pone.0252479.ref038","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1053\/j.ajkd.2010.11.029","article-title":"Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3\u20134 Study","volume":"57","author":"VE Torres","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"pone.0252479.ref039","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.juro.2012.06.026","article-title":"Long-term impact of laparoscopic cyst decortication on renal function, hypertension and pain control in patients with autosomal dominant polycystic kidney disease","volume":"188","author":"M Haseebuddin","year":"2012","journal-title":"J Urol"},{"issue":"3","key":"pone.0252479.ref040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4103\/0972-9941.140217","article-title":"Laparoscopic nephrectomy for autosomal dominant polycystic kidneys in patients with end-stage renal disease on maintenance hemodialysis: 10-year single surgeon experience from an Indian center","volume":"11","author":"GP Abraham","year":"2015","journal-title":"J Minim Access Surg"},{"issue":"6","key":"pone.0252479.ref041","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1053\/j.ajkd.2011.12.018","article-title":"Management of chronic pain in a patient with autosomal dominant polycystic kidney disease by sequential celiac plexus blockade, radiofrequency ablation, and spinal cord stimulation","volume":"59","author":"N Walsh","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"pone.0252479.ref042","doi-asserted-by":"crossref","first-page":"e0120696","DOI":"10.1371\/journal.pone.0120696","article-title":"Which Stage of ADPKD Is More Appropriate for Decortication? A Retrospective Study of 137 Patients from a Single Clinic","volume":"10","author":"X Qian","year":"2015","journal-title":"PLoS ONE"},{"key":"pone.0252479.ref043","article-title":"Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms","author":"BM Merskey H","year":"1994","journal-title":"Task Force on Taxonomy of the International Association for the Study of Pain (IASP)"},{"issue":"4","key":"pone.0252479.ref044","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11255-015-1211-x","article-title":"Long-term functional results of aspiration and sclerotherapy with ethanol in patients with autosomal dominant polycystic kidney disease: a non-randomized pilot clinical study","volume":"48","author":"EV Kucuk","year":"2016","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"pone.0252479.ref045","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0272-6386(00)70021-7","article-title":"Laparoscopic nephrectomy in patients with end-stage renal disease and autosomal dominant polycystic kidney disease","volume":"35","author":"MD Dunn","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"pone.0252479.ref046","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/089277903767923100","article-title":"Laparoscopic cyst decortication in autosomal dominant polycystic kidney disease: impact on pain, hypertension, and renal function","volume":"17","author":"DI Lee","year":"2003","journal-title":"J Endourol"},{"issue":"4","key":"pone.0252479.ref047","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/089277904323056942","article-title":"Hand-assisted laparoscopic nephrectomy in autosomal dominant polycystic kidney disease","volume":"18","author":"DI Lee","year":"2004","journal-title":"J Endourol"},{"issue":"6","key":"pone.0252479.ref048","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1097\/00005392-200106000-00011","article-title":"Laparoscopic cyst marsupialization in patients with autosomal dominant polycystic kidney disease","volume":"165","author":"MD Dunn","year":"2001","journal-title":"J Urol"},{"issue":"2","key":"pone.0252479.ref049","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.juro.2006.09.026","article-title":"Limitations of laparoscopy for bilateral nephrectomy for autosomal dominant polycystic kidney disease","volume":"177","author":"MC Lipke","year":"2007","journal-title":"J Urol"},{"issue":"27","key":"pone.0252479.ref050","doi-asserted-by":"crossref","first-page":"e11445","DOI":"10.1097\/MD.0000000000011445","article-title":"Should kidney volume be used as an indicator of surgical occasion for patients with autosomal dominant polycystic kidney disease?","volume":"97","author":"J Yu","year":"2018","journal-title":"Medicine"},{"issue":"1","key":"pone.0252479.ref051","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0022-5347(05)66072-7","article-title":"Laparoscopic bilateral hand assisted nephrectomy for autosomal dominant polycystic kidney disease: initial experience","volume":"166","author":"J Rehman","year":"2001","journal-title":"J Urol"},{"issue":"1","key":"pone.0252479.ref052","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.transproceed.2005.11.082","article-title":"Laparoscopic removal of renal cysts in patients with ADPKD as an alternative method of treatment and patient preparation for kidney transplantation: preliminary results","volume":"38","author":"T Sulikowski","year":"2006","journal-title":"Transplant Proc"},{"key":"pone.0252479.ref053","unstructured":"Central Sensitisation Inventory. Available at https:\/\/wwwphysio-pediacom\/Central_Sensitisation_Inventory [last access September 2020]."},{"key":"pone.0252479.ref054","unstructured":"OMERACT. Working Group name: Pain. https:\/\/omeractorg\/working-groups\/pain\/."},{"key":"pone.0252479.ref055","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.3899\/jrheum.090365","article-title":"OARSI\/OMERACT Criteria of Being Considered a Candidate for Total Joint Replacement in Knee\/Hip Osteoarthritis as an Endpoint in Clinical Trials Evaluating Potential Disease Modifying Osteoarthritic Drugs","author":"M Dougados","year":"2009","journal-title":"J Rheumatol"},{"key":"pone.0252479.ref056","doi-asserted-by":"crossref","first-page":"409e14","DOI":"10.1016\/j.joca.2007.12.015","article-title":"Development and preliminary psychometric testing of a new OA pain measure e an OARSI\/OMERACT initiative","volume":"16","author":"GA Hawker","year":"2008","journal-title":"Osteoarthritis and Cartilage"},{"key":"pone.0252479.ref057","unstructured":"PROMIS pain measures. Available at https:\/\/wwwhealthmeasuresnet\/search-view-measures [last access September 2020]."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0252479","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T15:32:38Z","timestamp":1622129558000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0252479"}},"subtitle":[],"editor":[{"given":"Ali","family":"Montazeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,5,27]]},"references-count":57,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0252479","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,27]]}}}